Zogenix, Inc. (ZGNX) Stock Ratings


View Stock Quote:

Login Required

You must login before you can rate this stock.

Login Now

Community Rating:


Bullish

100% of 7 ratings
View All-Time Ratings

Do the wall street analysts agree?

Consensus Recommendation:

View detailed analyst research

Other Member Ratings

View Most Rated Stocks
Member Call Date Rated Timeframe Start Price End Price Stock Gain/Loss Score Status
360PHARMACOLOGY 360PHARMACOLOGY 04/22/2014 3 months $2.98 $3.01 +1.01% 1 Active
Comments: Zohydro is like Zomorph in terms of capsule design, no one complains about that.
CoalRegion CoalRegion 04/21/2014 1 Year $2.71 $3.01 +11.07% 11 Active
Comments: I believe that zohydro er is a necessity for those with chronic pain problems
Joward Joward 02/22/2014 1 Year $4.68 $3.01 -35.68% -35 Active
Comments:
villanueva villanueva 02/22/2014 1 Year $4.68 $3.01 -35.68% -35 Active
Comments:
markrefuerzo markrefuerzo 02/20/2014 1 Year $4.61 $3.01 -34.71% -34 Active
Comments:
Klingtubby Klingtubby 02/16/2014 3 months $4.70 $3.01 -35.96% -35 Active
Comments:
sporter101 sporter101 01/09/2014 3 months $3.88 $2.59 -33.25% -33 Ended
Comments: sales will increase
Kreuz55 Kreuz55 01/08/2014 3 months $3.72 $2.46 -33.87% -33 Ended
Comments:
itssofluffyimgonnadie itssofluffyimgonnadie 01/07/2014 3 months $3.31 $2.58 -22.05% -22 Ended
Comments: still undervalued
Steed Steed 01/03/2014 1 Year $3.43 $3.01 -12.24% -12 Active
Comments: Blockbuster about to begin sales ... Read the full entry
jubei jubei 11/05/2013 1 day $2.54 $1.93 -24.02% 24 Ended
Comments:
innovator13 innovator13 03/01/2013 3 months $1.87 $1.45 -22.46% -22 Ended
Comments: buy-out could be very soon
prometheusX prometheusX 02/28/2013 3 months $1.70 $1.52 -10.59% -10 Ended
Comments: I believe in an FDA-approval.
TomPain TomPain 01/29/2013 3 months $1.43 $1.69 +18.18% 18 Ended
Comments: A family member is friends with one of a Zogenix' executives.
JOKER66 JOKER66 12/10/2012 1 day $2.36 $1.12 -52.54% 52 Ended
Comments:

Neither The NASDAQ OMX Group, Inc. nor any of its affiliates (collectively "NASDAQ OMX") makes any recommendation to buy or sell any security or any representation about the financial condition of any company. Investment related advice and comments are solely those of the individuals who publish them and do not in any way represent the opinions of NASDAQ OMX. Investors should undertake their own due diligence and carefully evaluate companies before investing.